TVTX icon

Travere Therapeutics

170 hedge funds and large institutions have $1.54B invested in Travere Therapeutics in 2022 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 55 increasing their positions, 67 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
170
Holders Change
+2
Holders Change %
+1.19%
% of All Funds
2.87%
Holding in Top 10
7
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-12.5%
% of All Funds
0.12%
New
24
Increased
55
Reduced
67
Closed
19
Calls
$4.14M
Puts
$1.91M
Net Calls
+$2.23M
Net Calls Change
+$236K
Name Holding Trade Value Shares
Change
Shares
Change %
N
176
Natixis
France
-$1.69M -65,392 Closed
JCIA
177
Jackson Creek Investment Advisors
Colorado
-$1.09M -42,121 Closed
Point72 Asset Management
178
Point72 Asset Management
Connecticut
-$858K -33,300 Closed
EGM
179
Engineers Gate Manager
New York
-$421K -16,331 Closed
Man Group
180
Man Group
United Kingdom
-$245K -9,500 Closed
PHK
181
Point72 Hong Kong
Hong Kong
-$140K -5,439 Closed
AS
182
Altshuler Shaham
Israel
-$37K -1,435 Closed
Bessemer Group
183
Bessemer Group
New Jersey
-$6K -221 Closed
T
184
TCWP
Ohio
-$2K -91 Closed
Kayne Anderson Rudnick Investment Management
185
Kayne Anderson Rudnick Investment Management
California
-$2K -72 Closed
Carson Wealth (CWM LLC)
186
Carson Wealth (CWM LLC)
Nebraska
-$2K -66 Closed